Developer docs
API playgroundTry for free, no card

Search company profiles

Heal Capital

Full company profile

uuid00029uc

Namestring
Heal Capital
Legal namestring
heal.capital Management GmbH
Websiteurl
healcapital.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Heal Capital is a Berlin-based venture capital fund manager (heal.capital Management GmbH) specializing exclusively in European HealthTech. Founded in 2019, the firm invests at Pre-Seed to Series A stages with €1–5M ticket sizes, focusing on software, AI, and digitally-enabled care models while excluding therapeutics, drug discovery, and pure hardware. The fund is registered as an alternative investment fund manager (AIFM) with BaFin under §2(4) KAGB and manages two successor funds: heal.capital I and the SFDR Article 8-classified heal.capital II. As of 2026, AUM exceeds €200M, backed by a consortium of 25+ European private health insurers (AXA, Allianz, DKV, ERGO, Gothaer, Signal Iduna, among others) and the European Investment Fund (EIF).

The fund's core proposition combines capital with curated market access. Portfolio companies gain introductions to the LP network as potential enterprise customers and distribution partners, supported by an Innovation Council of senior operators including the CEOs of Charité, B. Braun, and Sana Kliniken AG, the President of the German Medical Association, and a Member of the German Bundestag. The active portfolio spans 20+ companies across Germany, France, the UK, and the Netherlands (e.g., Infermedica, Hypervision Surgical, Paloma Health, Ditto, Gleamer), with four exits to date including Gleamer's sale to RadNet for up to €230M.

Revenue is generated through the standard VC model — annual management fees on committed/deployed AUM plus carried interest on realized returns above the hurdle. The firm deploys capital through direct sourcing, open Typeform pitch submissions, and LP referrals, and operates as lead or co-lead investor. Team composition includes two Founding Managing Partners (Eckhardt Weber, Christian Lautner), a Founding Partner (Dr. Markus Müschenich), a four-person Investment Team, Finance & Operations, two Venture Partners, and an Engineering Fellow.

Short descriptiontext

Heal Capital is a Berlin-based venture capital fund manager investing €1–5M in European HealthTech startups from Pre-Seed to Series A. Backed by 25+ health insurers and the EIF, it combines capital with curated access to senior healthcare operators and enterprise customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthtech venture capital, early-stage investing, digital health funding, fund management services, healthcare startup investment
Industry1 code
PRIMARYBPADACAO
Impact Investment & Development Investment Funds
Business & Public Services/International Organizations & Development/International Financial Institutions & Development Banks
NAICS code1 code
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
HealthTech Venture Capital / Fund Management
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeManaged Services
Description

Heal Capital generates revenue through management fees charged on the assets under management (AUM) of its funds, and through carried interest (performance fees) realized when portfolio companies achieve successful exits. This is the standard VC fund model.

healcapital.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Pre-Seed to Series A investments
ModelOtherBilling cadenceMulti-year contract
Notes

Ticket size of €1–5M per investment; stages from Pre-Seed through Series A; geographic focus on Europe; Heal Capital acts as lead or co-lead investor.

healcapital.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Heal Capital is a European venture capital fund that invests €1–5M tickets into Pre-Seed to Series A HealthTech startups focused on software, AI, and digitally-enabled care models. The fund acts as lead or co-lead investor and offers portfolio companies access to a network of 25+ European private health insurer and institutional healthcare LPs, plus an Innovation Council of healthcare, scientific, and political experts. The fund is managed by heal.capital Management GmbH and is registered as an AIFM with BaFin under the German Investment Code (KAGB).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Portfolio companies gain access to millions in ARR through Heal Capital's network connections.
Product overview1 text field

Heal Capital is a venture capital fund (not a product company) that operates as an investment vehicle for HealthTech startups. The fund focuses exclusively on digital health technologies, software, AI, and digitally-enabled care models. The fund provides funding (€1-5M ticket size) from Pre-Seed to Series A stages, with European geographic focus. The fund is managed by heal.capital Management GmbH and is registered as an alternative investment fund manager with BaFin under the German Investment Code (KAGB).

Product and service1 record
1Heal Capital Fund (heal.capital I & heal.capital II)
CategoryVenture Capital Fund
Description

A European venture capital fund dedicated exclusively to HealthTech that invests €1–5M tickets into Pre-Seed to Series A startups focused on software, AI, and digitally-enabled care models, acting as lead or co-lead investor. For founders of European HealthTech startups seeking capital, market access, and regulatory expertise.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Nordic-anchored early-stage VC with active digital health investments across Europe. Comparable stage and HealthTech exposure, though broader tech mandate and Nordic bias.

TypeDirect peer
Description

Munich-based European early-stage VC with a dedicated medical technology / digital health practice. Comparable in stage, German/European focus, and healthcare specialization.

TypeBroad incumbent
Description

Munich-based growth-stage VC with consumer and healthcare investments. Overlaps with Heal Capital in DACH focus and healthcare exposure but targets larger later-stage rounds.

TypeDirect peer
Description

Berlin-headquartered pan-European early-stage VC with a long-standing digital health investment practice. Comparable to Heal Capital in stage, DACH focus, and HealthTech specialization; competes for similar founders and LP mindshare in the German market.

TypeDirect peer
Description

Austrian early-stage VC with a dedicated Health & Wellbeing vertical investing across Europe. Comparable to Heal Capital in stage (Pre-Seed to Series A), geography (DACH + broader Europe), and ticket size — making it the most directly comparable competitor for HealthTech deal flow in Europe.

TypeDirect peer
Description

Cologne-headquartered European VC with healthcare as one of its core verticals across Pre-Seed to Growth stages. Comparable to Heal Capital in DACH focus and healthcare exposure, though broader sector mandate (also consumer, fintech, enterprise software).

TypeDirect peer
Description

Vienna-based health-focused early-stage VC investing across Europe. Highly comparable in HealthTech-only thesis, European footprint, and early-stage tickets.

TypeDirect peer
Description

Corporate-affiliated European HealthTech investor (Angelini Group) that co-invested alongside Heal Capital in Hypervision Surgical. Comparable in HealthTech-only thesis and European early-stage tickets.

TypeDirect peer
Description

European VC with a dedicated Digital Health fund and presence in Berlin, Munich, and Zurich. Comparable to Heal Capital in early-stage HealthTech focus, ticket size, and European geographic scope.

TypeDirect peer
Description

Munich-based early-stage impact VC with significant HealthTech exposure. Comparable in stage, geography (DACH), and impact/ESG orientation (similar to Heal Capital's SFDR Article 8 positioning).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment39 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Heal Capital

HealthTech Venture Capital / Fund Managementhealcapital.com

Heal Capital is a Berlin-based venture capital fund manager investing €1–5M in European HealthTech startups from Pre-Seed to Series A. Backed by 25+ health insurers and the EIF, it combines capital with curated access to senior healthcare operators and enterprise customers.

What Heal Capital does

Heal Capital is a Berlin-based venture capital fund manager (heal.capital Management GmbH) specializing exclusively in European HealthTech. Founded in 2019, the firm invests at Pre-Seed to Series A stages with €1–5M ticket sizes, focusing on software, AI, and digitally-enabled care models while excluding therapeutics, drug discovery, and pure hardware. The fund is registered as an alternative investment fund manager (AIFM) with BaFin under §2(4) KAGB and manages two successor funds: heal.capital I and the SFDR Article 8-classified heal.capital II. As of 2026, AUM exceeds €200M, backed by a consortium of 25+ European private health insurers (AXA, Allianz, DKV, ERGO, Gothaer, Signal Iduna, among others) and the European Investment Fund (EIF).

The fund's core proposition combines capital with curated market access. Portfolio companies gain introductions to the LP network as potential enterprise customers and distribution partners, supported by an Innovation Council of senior operators including the CEOs of Charité, B. Braun, and Sana Kliniken AG, the President of the German Medical Association, and a Member of the German Bundestag. The active portfolio spans 20+ companies across Germany, France, the UK, and the Netherlands (e.g., Infermedica, Hypervision Surgical, Paloma Health, Ditto, Gleamer), with four exits to date including Gleamer's sale to RadNet for up to €230M.

Revenue is generated through the standard VC model — annual management fees on committed/deployed AUM plus carried interest on realized returns above the hurdle. The firm deploys capital through direct sourcing, open Typeform pitch submissions, and LP referrals, and operates as lead or co-lead investor. Team composition includes two Founding Managing Partners (Eckhardt Weber, Christian Lautner), a Founding Partner (Dr. Markus Müschenich), a four-person Investment Team, Finance & Operations, two Venture Partners, and an Engineering Fellow.

Heal Capital firmographics

Firmographics
Name
Heal Capital
Legal name
heal.capital Management GmbH
Website
https://healcapital.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Heal Capital is a Berlin-based venture capital fund manager investing €1–5M in European HealthTech startups from Pre-Seed to Series A. Backed by 25+ health insurers and the EIF, it combines capital with curated access to senior healthcare operators and enterprise customers.
Ownership category
akta.pro rank

Heal Capital industry classification

Industry
Product category
HealthTech Venture Capital / Fund Management
NAICS
Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYBPADACAO
Impact Investment & Development Investment Funds
Business & Public Services/International Organizations & Development/International Financial Institutions & Development Banks

Keywords

  • Healthtech venture capital
  • Early-stage investing
  • Digital health funding
  • Fund management services
  • Healthcare startup investment

Where Heal Capital is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Heal Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Fund Management: Heal Capital generates revenue through management fees charged on the assets under management (AUM) of its funds, and through carried interest (performance fees) realized when portfolio companies achieve successful exits. This is the standard VC fund model.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPre-Seed to Series A investments

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Heal Capital product offering

Product offering

Core offering

Heal Capital is a European venture capital fund that invests €1–5M tickets into Pre-Seed to Series A HealthTech startups focused on software, AI, and digitally-enabled care models. The fund acts as lead or co-lead investor and offers portfolio companies access to a network of 25+ European private health insurer and institutional healthcare LPs, plus an Innovation Council of healthcare, scientific, and political experts. The fund is managed by heal.capital Management GmbH and is registered as an AIFM with BaFin under the German Investment Code (KAGB).

Product overview

Heal Capital is a venture capital fund (not a product company) that operates as an investment vehicle for HealthTech startups. The fund focuses exclusively on digital health technologies, software, AI, and digitally-enabled care models. The fund provides funding (€1-5M ticket size) from Pre-Seed to Series A stages, with European geographic focus. The fund is managed by heal.capital Management GmbH and is registered as an alternative investment fund manager with BaFin under the German Investment Code (KAGB).

Differentiator

Problem solved

Functional benefit

Products and services

  • Heal Capital Fund (heal.capital I & heal.capital II) A European venture capital fund dedicated exclusively to HealthTech that invests €1–5M tickets into Pre-Seed to Series A startups focused on software, AI, and digitally-enabled care models, acting as lead or co-lead investor. For founders of European HealthTech startups seeking capital, market access, and regulatory expertise.

Quantifiable outcome

  • Portfolio companies gain access to millions in ARR through Heal Capital's network connections.

Companies that use Heal Capital

Customer profile

Named customers5 records

Segments1 record

Ideal customer profiles2 records

Heal Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Heal Capital partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Heal Capital competitors and assessment

Company assessment

Direct peers

  • Creandum: Nordic-anchored early-stage VC with active digital health investments across Europe. Comparable stage and HealthTech exposure, though broader tech mandate and Nordic bias.
  • Wellington Partners: Munich-based European early-stage VC with a dedicated medical technology / digital health practice. Comparable in stage, German/European focus, and healthcare specialization.
  • Earlybird Venture Capital: Berlin-headquartered pan-European early-stage VC with a long-standing digital health investment practice. Comparable to Heal Capital in stage, DACH focus, and HealthTech specialization; competes for similar founders and LP mindshare in the German market.
  • Speedinvest: Austrian early-stage VC with a dedicated Health & Wellbeing vertical investing across Europe. Comparable to Heal Capital in stage (Pre-Seed to Series A), geography (DACH + broader Europe), and ticket size — making it the most directly comparable competitor for HealthTech deal flow in Europe.
  • HV Capital: Cologne-headquartered European VC with healthcare as one of its core verticals across Pre-Seed to Growth stages. Comparable to Heal Capital in DACH focus and healthcare exposure, though broader sector mandate (also consumer, fintech, enterprise software).
  • Calm/Storm Ventures: Vienna-based health-focused early-stage VC investing across Europe. Highly comparable in HealthTech-only thesis, European footprint, and early-stage tickets.
  • Angelini Ventures: Corporate-affiliated European HealthTech investor (Angelini Group) that co-invested alongside Heal Capital in Hypervision Surgical. Comparable in HealthTech-only thesis and European early-stage tickets.
  • btov Partners: European VC with a dedicated Digital Health fund and presence in Berlin, Munich, and Zurich. Comparable to Heal Capital in early-stage HealthTech focus, ticket size, and European geographic scope.
  • Ananda Impact Ventures: Munich-based early-stage impact VC with significant HealthTech exposure. Comparable in stage, geography (DACH), and impact/ESG orientation (similar to Heal Capital's SFDR Article 8 positioning).

Broad incumbents

  • Acton Capital: Munich-based growth-stage VC with consumer and healthcare investments. Overlaps with Heal Capital in DACH focus and healthcare exposure but targets larger later-stage rounds.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Heal Capital social profiles

Digital presence

Heal Capital compliance and trust

Trust signal

Compliance4 records

Heal Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Heal Capital leadership team

Management profile

Number of profiles

Profiles11 records

Heal Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Heal Capital M&A and investment

M&A and investment

M&A

Investments39 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heal Capital

What does Heal Capital do?

Heal Capital is a European venture capital fund that invests €1–5M tickets into Pre-Seed to Series A HealthTech startups focused on software, AI, and digitally-enabled care models. The fund acts as lead or co-lead investor and offers portfolio companies access to a network of 25+ European private health insurer and institutional healthcare LPs, plus an Innovation Council of healthcare, scientific, and political experts. The fund is managed by heal.capital Management GmbH and is registered as an AIFM with BaFin under the German Investment Code (KAGB).

Is Heal Capital a public or private company?

Heal Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Heal Capital founded?

Heal Capital was founded in 2021. It employs 11 to 50 people.

Where is Heal Capital based?

Heal Capital is headquartered in Berlin, Germany, in the Europe region.

How does Heal Capital make money?

One revenue line is on record: fund Management.

Who are Heal Capital's main competitors?

Direct peers on record are Creandum, Wellington Partners, Earlybird Venture Capital, Speedinvest, HV Capital, Calm/Storm Ventures, Angelini Ventures, btov Partners and Ananda Impact Ventures. Acton Capital is listed as a broad incumbent.

Does Heal Capital have an API?

No public API is recorded for Heal Capital.

What industry is Heal Capital in?

Heal Capital's product category is HealthTech Venture Capital / Fund Management. Its primary akta.pro industry code is BPADACAO, Impact Investment & Development Investment Funds. Its NAICS code is 525 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceAitiologic Raises €6.4 Million in Oversubscribed Seed Financing to Advance Tissue-Resolved Liquid Biopsy Platform and Preeclampsia Lead ProgramAitiologic closed a €6.4 million seed financing co-led by Heal Capital and Ananda Impact Ventures to advance its Aitios platform for preeclampsia risk stratification. The company will use the funds for large-scale validation in over 1,000 pregnancies and appointed Dr. Rebecca Ertl as Chief Medical Officer.StartbaseTokura secures seed funding for the future of outpatient surgeryTokura, a Berlin-based healthtech startup, raised a mid-seven-figure seed round led by Heal Capital and Redalpine. The capital will fund its first location and technology platform for outpatient surgery infrastructure. The company aims to enable up to one million outpatient operations annually.VestbeeDutch AI healthtech startup Ditto raises €7.6M led by Heal CapitalDitto, a Dutch AI healthtech startup, raised €7.6 million in a funding round led by Heal Capital. The company's app converts medical consultations and documents into plain-language summaries, and has reached nearly 100,000 users. The funds will support European expansion and new features.StartbaseHeal Capital invests in DittoDitto, a Dutch healthtech startup, closed a 7.6 million euro seed round led by Heal Capital. The AI app translates doctor's consultations into simple language and has been downloaded around 100,000 times since its 2025 launch. Funds will support expansion into the DACH region by 2026.The Next WebDuch Ditto raises €7.6M for patient-side AI summaries of medical appointmentsDitto, an Amsterdam-based health-tech, raised €7.6M led by Heal Capital to expand into Germany, the UK, and Spain. The company's patient-side AI summaries aim to help patients retain medical information, with 100,000 Dutch users and 4.7-star ratings. It plans to deepen into appointment preparation.StartupmagHypervision Surgical raises £17m to reduce surgical leaks with hyperspectral imagingHypervision Surgical raised an oversubscribed £17m Series A to commercialize its hyperspectral imaging platform for surgery. The funds will support clinical deployment of HYPERSNAP, a next-generation sensor with imec, and cloud-enabled AI analytics. The company holds UK and US regulatory clearance for its system.StartupriseCGC Genomics funding news – Basel-based CGC Genomics Secures €1.7 Million in Pre-Seed FundingBasel-based CGC Genomics raised €1.7 million in pre-seed funding to develop its GenAI platform Qnomx, which aims to help doctors interpret cancer genome data for better treatment decisions. The funding comes from Heal Capital, Becker Ventures, and others, with plans to launch Qnomx as the first regulatory-compliant generative AI tool for cancer diagnosis.FormlyFormlyAI raises $2M led by Heal Capital to revolutionize medical device compliance using AIFormlyAI closed a $2M seed round led by Heal Capital to expand in the US and EU. The AI-powered platform has saved clients an average of $70K and cut time-to-market tenfold. The company plans to expand into Canada and Asian markets by year-end.UktechnewsHeim Health secure £2.2 million Seed Investment led by Heal CapitalHeim Health raised a £2.2 million seed round led by Heal Capital to expand its at-home healthcare platform. The company sources and deploys nurses for home care, aiming to reduce hospital pressure. The funds will develop algorithms and support NHS partnerships.BdailyHealthcare operator raises £2.2 million to expandLondon-based Heim Health raised £2.2 million in funding led by Heal Capital to expand its digital at-home care platform. The platform connects healthcare providers with practitioners for tasks like blood tests and post-operative care, aiming to reduce hospital waitlists. It plans to expand partnerships with the NHS and primary care providers.